LGC – DDS Products

LGC's LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies. Read more...

LGC's expert biomarker teams support non-clinical and clinical biomarker method development, validation and sample analysis. LGC's capabilities span from measuring single to multiple analyte profiles, such as those employed to mon... Read more...

LGC's flow cytometry service offers a range of assays to support pre-clinical through to late phase drug development.  Read more...

LGC's bioanalytical solutions have helped their clients develop new peptide therapeutics to improve the quality of life.  Applying their experience and cutting-edge technology, LGC have developed and validated methods using ... Read more...

LGC has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 200 scientists across three UK facilities. Read more...

Focused strategic science team, and one of the largest purpose-built bioanalytical facilities in Europe. Read more...

LGC scientists are highly skilled in the accurate quantification of trace metals in challenging matrices. Offering you in-depth technical knowledge and extensive experience in the quantitation of elemental impurities in pharmaceutical mat... Read more...

LGC are highly experienced in contamination investigations and the accurate quantification of trace levels of organic and inorganic impurities (down to sub-ppb levels) in materials. LGC facilities have been inspected by the UK MHRA for cG... Read more...